Immunogenetic Determinants of Parkinson’s Disease Etiology

View Article

Parkinson’s disease (PD) is increasingly recognised as a systemic disorder in which inflammation might play a causative role rather than being a consequence or an epiphenomenon of the neurodegenerative process. Although growing genetic evidence links the central and peripheral immune system with both monogenic and sporadic PD, our understanding on how the immune system contributes to PD pathogenesis remains a daunting challenge. In this review, we discuss recent literature aimed at exploring the role of known genes and susceptibility loci to PD pathogenesis through immune system related mechanisms. Furthermore, we outline shared genetic etiologies and interrelations between PD and autoimmune diseases and underlining challenges and limitations faced in the translation of relevant allelic and regulatory risk loci to immune-pathological mechanisms. Lastly, with the field of immunogenetics expanding rapidly, we place these insights into a future context highlighting the prospect of immune modulation as a promising disease-modifying strategy.

Training and Networking Working Group

The Training and Networking working group promotes training and networking throughout the GP2 project.
Learn more about Training and Networking Working Group

Meet the authors

PhD student, PhD student

Pin-Jui Kung, MSc

Genome and systems biology degree program, National Taiwan University | Taiwan

Assistant Professor & Researcher

Inas Elsayed

Faculty of pharmacy University of Gezira | Sudan

PhD Student

Paula Reyes-Pérez, MSc

Universidad Nacional Autónoma de México | Mexico

Staff Scientist

Sara Bandres-Ciga, PharmD,PhD

National Institutes of Health | USA